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http://dx.doi.org/10.1016/j.jfma.201Previous studies have used cryotherapy for the treatment of oral precancers including oral leu-
koplakia (OL) and oral verrucous hyperplasia (OVH) as well as oral cancers including oral ver-
rucous carcinoma (OVC) and oral squamous cell carcinoma (OSCC). Cryotherapy is a method
that locally destroys lesional tissues by freezing in situ. It can be carried out by either an
“open” or a “closed” system. Lesional tissues are destroyed mainly through disruption of cell
membrane, cellular dehydration, enzyme and protein damage, cell swelling and rupture, ther-
mal shock injury to cells, damage to vasculature, and immune-mediated cytotoxicity. Cryo-
therapy is used frequently for the treatment of OL lesions with promising results. It can also
be used to treat OVH and OVC lesions. Because OVH and OVC lesions are usually fungating
and bulky, a combination therapy of shave excision and cryotherapy is needed to achieve a
complete regression of the lesion. OSCCs have also been treated by cryotherapy. However,
cryotherapy is not the main-stream treatment modality for OSCCs. Cryotherapy seems suitable
for treatment of thin or relatively thick plaque-typed lesions such as OL lesions. By careful se-
lection of patients, cryotherapy is a simple, safe, easy, conservative, and acceptable treat-
ment modality for certain benign oral lesions and oral precancers.
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Oral squamous cell carcinoma (OSCC) is the most frequent
malignant tumor of the oral cavity and the sixth most
common cancer in the world.1 OSCCs consist of more than
90% of oral malignancies. Oral verrucous carcinoma (OVC) is
a low-grade variant of OSCC, which represents 1e10% of all
OSCCs.2 In Taiwan, oral cancers rank as the sixth most
prevalent cancer in both genders and account for the fourth
most common cancers in males.3 Although great advances
have been made in the diagnosis and treatment of OSCC in
recent years, the 5-year survival rate for patients with
advanced stages of oral cancer has remained approximately
20%.4 Oral precancerous lesions are even much more
prevalent than oral cancers. Without further interventions,
a part of these oral precancerous lesions finally transform
into oral cancers. Therefore, finding a simple, safe, easy,
conservative, and acceptable treatment modality to erad-
icate oral precancers, thereby preventing their further
malignant transformation is one of the best strategies to
prevent the occurrence of oral cancer.
Oral leukoplakia (OL), oral erythroleukoplakia (OEL),
and oral verrucous hyperplasia (OVH) are three common
oral precancerous lesions. Histologically, approximately
90% of OL lesions show hyperkeratosis and/or epithelial
hyperplasia, 5% epithelial dysplasia or carcinoma in situ,
and another 5% invasive carcinoma. The malignant trans-
formation rates of OL lesions have been reported to be
1e7% for homogenous thick leukoplakia and 4e15% for
granular or verruciform leukoplakia.2 However, approxi-
mately 50% of OEL lesions reveal some degree of epithelial
dysplasia or carcinoma in situ, and another 50% superfi-
cially invasive carcinoma.2 OEL has a higher malignant
transformation rate of 18e47%, which is higher than that of
OL lesions.2 In Taiwan, both betel quid chewing and ciga-
rette smoking are involved in multistate progression of oral
precancers including OL and OEL lesions.5,6 A cohort study
found an average dwelling period of 24 years and 7 years for
OL and OEL, respectively. Furthermore, the risks of devel-
oping oral cancer after 20 years of follow up are 42.2% for
OL and 95.0% for OEL.6 These findings suggest that OEL
lesions have higher malignant transformation potential
than OL lesions. A retrospective clinical study showed a
malignant transformation rate of 3.1% and a mean malig-
nant transformation duration of 54.6 months for 324 OVH
lesions in Taiwanese patients.7 Wang et al8 also demon-
strated a 5-year malignant transformation rate of 3% for 30
plaque-typed and 17% for 30 mass-typed OVH lesions. The
high malignant transformation rates of OL, OEL, and OVH
lesions highlight the importance of early detection and
treatment of these three types of oral precancerous
lesions.
Although oral precancerous lesions can be eradicated by
surgical excision,9 laser surgery,10,11 and photodynamic
therapy (PDT),12 cryotherapy is also an effective and
alternative treatment modality for oral precancers.13e26
Cryotherapy is a method that locally destroys lesional tis-
sues by freezing in situ.27 It has several advantages
including bloodless treatment, a very low incidence of
secondary infections, and a relative lack of scarring and
pain.20e22 Cryotherapy can be carried out with either aclosed or an open system.13e26 Closed-system cryotherapy
offers a greater degree of temperature control but requires
a complex, delicate, and expensive equipment.13e19 It is
performed by direct contact of the cryoprobe onto the
lesional surface. Because of the small and flat contact area
of the cryoprobe end, closed-system cryotherapy is usually
suitable for treatment of uniform, smooth-surfaced oral
lesions less than 1 cm in diameter.13e19 Open-system
cryotherapy involves directly applying the cryogen to the
lesion with either a cotton swab20,21 or a portable spray
apparatus.22e26 It is more difficult to maintain a constant
lower temperature in the lesional tissues during the whole
treatment period. However, it does not need an expensive
equipment. Open-system cryotherapy with the spray
apparatus is suitable for treatment of medium and large
oral lesions with either a smooth or rough surface.22e26
In this article, we reviewed the previous studies evalu-
ating the efficacies of close- and open-system cryotherapy
treatments on oral precancers including OL13e25 and OVH26
and oral cancers including OVC and OSCC.17,25,26,28e32
Because OVH and OVC are exophytic and bulky lesions
that are difficult to treat by simple cryotherapy, we also
reviewed a study assessing the effects of combination
therapy of shave excision and subsequent cryotherapy on
OVH and OVC lesions.26
Mechanisms of tissue destruction by cryotherapy
The mechanisms for cell destruction after cryotherapy are
complex involving a combination of direct and indirect ef-
fects.16,33,34 Direct effects consist of extracellular and
intracellular formation of ice crystals, which in turn disrupt
cell membranes,16,34 cellular dehydration, toxic intracel-
lular electrolyte concentration, inhibition of enzymes,
protein damage, thawing effects that cause the cell to
vacuolate, swell, and rupture,16,33 and thermal shock injury
to cells.33 Indirect effects are vascular changes that lead to
ischemic necrosis of the treated tissue and immunological
responses that cause cell damage through a cytotoxic im-
mune mechanism.16,33
Tissue changes after cryotherapy
Clinical observations
The clinical responses of oral soft tissues to cryotherapy
usually include courses of tissue edema, subepithelial
hemorrhage, blister formation, necrosis, sloughing, and
repair. The degree of tissue destruction and the rate of
tissue regeneration after cryotherapy are slightly different
and depend on the size and location of the lesion and the
cryotherapy system used. In general, hyperemia, edema, or
erythema appears immediately or within a few hours after
cryotherapy. Local swelling develops and increases for 1e2
days, followed by superficial necrosis and an ulceration
covered by a layer of whitish or yellowish necrotic pseu-
domembrane. The whitish or yellowish slough separates
from the underlying tissue within the 1st week leaving a
clean, granulating surface that is partially covered by the
epithelium. Epithelialization is complete after 1e4 weeks
with no or very little scar formation.20,35,36
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There are very few reports with regard to the histological
tissue responses after cryotherapy. Hurt and colleagues35
used cryotherapy for treating periodontal disease of a 33-
year-old male to see the histological changes after treat-
ment. They observed a marked edema with vesicle forma-
tion just deep to the basal cell layer of the gingival
epithelium immediately after cryotherapy. They also found
a striking hyperemia with many engorged vessels in the
connective tissue near the vesicle. Three days after cryo-
therapy, the outer surface of the treated area is ulcerated
and covered by a fibrinous exudate incorporating many
neutrophils. The connective tissue underneath the ulcer is
edematous and exhibits an infiltrate of lymphocytes,
plasma cells, and neutrophils. Some eosinophilic ghost cells
and multinucleated epithelial giant cells that contain 2e20
nuclei within an eosinophilic cytoplasm are also noted.
Complete epithelial coverage with minimal disturbance of
the deep gingival structure is seen at Day 7 after cryo-
therapy. The connective tissue appears slightly hyalinized
with a diffuse plasma cell and lymphocyte infiltrate. Six
weeks after cryotherapy, the treated site reveals an intact
outer epithelium with no evidence of cryotherapy
histologically.35
Tal et al36 used cryotherapy to treat an extensive OL in a
63-year-old white female. Four weeks after cryotherapy,
they excised residual leukoplakia with a 2-mm margin of
treated mucosa, and the specimen was processed for his-
tological examination. They found that the treated
epithelium that is parakeratinized or nonkeratinized shows
some intracellular edema in the upper spinous cell layer.
The untreated epithelium was markedly hyper-
orthokeratotic with a prominent granular cell layer. Peri-
odic acideSchiff stain revealed a well-demarcated
boundary between the treated and untreated epithelium.
The treated epithelium contained a large amount of
glycogen in the spinous cell layer, whereas the untreated
hyperkeratotic epithelium was almost entirely lacking in
glycogen. There was only a mild chronic inflammatory cell
infiltrate in the superficial lamina propria of the treated
mucosa, whereas the infiltrate was fairly dense in the un-
treated mucosa.36Closed-system cryotherapy for OL
Closed-system cryotherapy has been used for treatment
of OL lesions with promising clinical outcomes.13e19 Sako
et al14 treated OL lesions in 60 patients using a special
cryosurgical unit, and all OL lesions showed complete
regression (CR) after one to five treatments. Chapin and
Burkes15 used cryotherapy with a gold cryoprobe to treat
four patients with dysplastic and nondysplastic OL lesions
and observed CR of all lesions after one or two treat-
ments. Leopard16 used closed-system cryotherapy with
two consecutive freezeethaw cycles of up to 1.5 minutes
to treat over 40 OL lesions in a 3-year period; only two
extensive and long-term OL lesions failed to respond.
Bekke and Baart17 used cryotherapy with a cryoprobe to
treat 35 OL lesions in 24 patients; all lesions showed CR
after one to four treatments. Al-Drouby18 used cryo-
therapy with a cryoprobe to treat 30 OL lesions in 30patients; 23 had complete removal, six had partial
removal, and there was no response in one patient.
Kawczyk-Krupka et al19 used cryotherapy with a contact
scapular probe to treat 37 patients with OL; a complete
response was obtained in 33 patients (89.2%) and recur-
rence was observed in nine patients (24.3%).
Open-system cryotherapy for OL
Open-system cryotherapy is carried out by the direct appli-
cation of either carbon dioxide snow or liquid nitrogen to OL
lesions by the cotton swab or open spray.20e26 Yeh20 used
cotton-swab cryotherapy to treat 102 oral lesions including
25 OL lesions. He demonstrated that small, superficial le-
sions show CR after one treatment, but deep, large lesions
need from two to four treatments to achieve CR. Our pre-
vious study used the cotton-swab cryotherapy to treat 60 OL
lesions and found CR of all OL lesions after an average of 6.3
treatments.21 Recently, we used the liquid nitrogen spray
with a cryogun (cryogun cryotherapy) to treat 60 OL lesions
that showed CR after an average of 3.1 treatments.22 Cryo-
gun cryotherapy seems more efficient than cotton-swab
cryotherapy to treat OL lesions, because the former needs
approximately half of the treatment number to achieve CR
of nearly equal-sized OL lesions compared with the latter. In
fact, the cotton swab carries only a small amount of liquid
nitrogen that cannot maintain a constant low temperature in
the treated lesional tissues. By contrast, special spray
equipment such as a cryogun can deliver a relatively large
amount of liquid nitrogen onto the lesional surface thereby
maintaining a more constant, lower temperature in treated
lesional tissues. This can further explain why the cryogun
cryotherapy is more efficient for the treatment of OL lesions
than the cotton-swab cryotherapy. In addition, we also
discovered that OL lesions on oral mucosal sites other than
the tongue, smaller than 2 cm2, with epithelial dysplasia, or
with a surface keratin thickness< 55 mm require significantly
fewer cryotherapy treatments to achieve CR than the cor-
responding OL lesions, respectively, when OL lesions are
treated by either the cotton-swab or cryogun cryo-
therapy.21,22 Miller23 used a single liquid nitrogen spray for
45e60 seconds to treat OL lesions on the hard palate, soft
palate, and buccal mucosa; all OL lesions were successfully
eliminated after treatment. Goode and Spooner24 used
liquid nitrogen spray to treat OL lesions in 20 patients and
observed CR of all OL lesions after one to four treatments.
Gongloff and Gage25 used liquid nitrogen spray of two
consecutive freezeethaw cycles to treat seven OL lesions;
CR of all OL lesions was achieved after a single treatment.
The results of the aforementioned studies indicate that
either closed-system or open-system cryotherapy is very
effective for the treatment of OL lesions.
Cryotherapy for OVH and OVC
Yeh20 treated 16 OVH lesions in 13 patients with the cotton-
swab cryotherapy. All 16 OVH lesions showed CR after one
to four cryotherapy treatments. However, four OVH lesions
recurred after a mean follow-up period of 26 months
(range: 3e46 months). The recurrent lesions were suc-
cessfully treated by additional cryotherapy. Yeh26 also
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combination therapy of shave excision and subsequent
simple cryotherapy. Eighteen of the 20 patients were fol-
lowed up. The CR of the tumor was found in 11 lesions, and
small and discrete residual tumors were noted in seven
lesions, which were further removed by electrosurgery or
CO2 laser surgery. After a mean follow-up period of 23
months (range: 6e46 months), recurrence was found in
three cases, wherein the lesions developed elsewhere;
however, all of them were successfully treated by the same
combination therapy.26Cryotherapy for OSCC
There are relatively fewer clinical reports with regard to
the use of cryotherapy for oral malignant lesions. Most of
these studies were reported predominantly between 1960
and 1980. In 1965, Gage and colleagues28 used cryotherapy
to treat three OSCCs and one adenoid cystic carcinoma,
which all showed CR after multiple cryotherapy treat-
ments. Three years later, Gage29 extended his study to
treat 50 oral and oropharyngeal cancers. The reasons for
selecting cryotherapy as the main treatment modality are
resistance to radiotherapy, location in areas difficult to
excise, desire to avoid the bone resection, and presence of
severe cardiopulmonary diseases.29 Of the 50 patients, 39
were treated with the intent to cure the disease and 11
were treated for palliation because of the extensive can-
cer. Among the former 39 patients, 30 are in good condition
and nine died after the treatment. For the latter 11 pa-
tients, although there was a reduction in pain and the
tumor size, eight patients died after treatment. Moreover,
of the 24 patients treated more than a year ago, three
failed to control the primary lesion, four died of heart
disease or metastatic cancer, and 17 are alive and appar-
ently well.29 In 1969, Gage30 used cryotherapy to treat 49
OSCC patients including five with oral cancer that was
persistent even after excision or radiotherapy and 44 with
oral cancer that was primarily treated by cryotherapy. Of
the former five OSCC patients, two are apparently free of
disease and three died after treatment. For the latter 44
OSCC patients, 14 have Stage I, 19 Stage II, nine Stage III,
and two Stage IV cancers. Moreover, of the latter 44 OSCC
patients, 27 without cervical lymphadenopathy were
treated with cryotherapy only and 17 with cervical lymph
node metastases were treated with cryotherapy and radical
neck dissection. With the observation period varying from a
few months to 5 years, 31 patients are alive and apparently
well, five patients died of unrelated diseases (such as heart
failure or coronary artery thrombosis), five died due to
recurrent cancer in the neck or with distant metastatic
disease, and three still have persistent cancer in the pri-
mary site.30 In 1976, Gage31 reported 60 OSCC patients
treated with cryotherapy. Of the 60 OSCC patients, 25 are
still alive with a mean survival period of 94 months, 16 died
of unrelated diseases, 10 died of metastatic tumors with no
cancer in the treated area, and nine died of persistent
primary cancers.31 He concluded that cryosurgery can be
used in carefully selected OSCC patients and it is the most
successfully used treatment on small- to moderate-sized
cancers without cervical lymphadenopathy.31Weaver and Smith32 reported 50 oropharyngeal SCC pa-
tients successfully treated with cryotherapy. Of the 50
patients, 30 are alive and in good condition; 12 died of
unrelated diseases with no evidence of cancer; and five
died due to residual local cancers, and three died due to
metastatic cancers after a follow-up period of 3e6 years.32
Bekke and Baart17 used cryotherapy as the primary and
proposedly curative therapy for 15 oral malignant tumors
and as the secondary but proposedly curative therapy for
six oral malignant tumors that had persisted after radio-
therapy or surgical excision. After an average follow-up
period of 30 months(range: 11e57 months), 13 patients
are still alive and eight patients died. Of the 13 survivors,
nine are free from tumor after cryosurgery, two are free
from tumor after supplemental therapy, and two are still
under supplemental therapy. Of the eight deceased pa-
tients, five were free from tumor and three had tumor
remnants at the time of death.17 Gongloff and Gage25
treated six superficially invasive OSCCs and two oral carci-
noma in situ lesions with cryotherapy. All lesions show CR
and no recurrence was noted after a follow-up period of
30e54 months.
Combination therapy of cryotherapy and other
treatment modalities
Chang and Yu37 used PDT combined with cryotherapy to
treat a large OVH and achieved CR of the lesion after six
treatments of combination therapy. In that study, cryogun
cryotherapy was performed immediately after topical 5-
aminolevulinic acid-mediated PDT (topical ALA-PDT) at
the same visit.37 Cryogun cryotherapy can also be used prior
to topical ALA-PDT at the same visit to facilitate the
diffusion of ALA into the precancerous and cancerous
epithelial cells to improve the clinical outcome of topical
ALA-PDT.12,38 By our clinical experience, hyperkeratotic OL
lesions respond poorly to topical ALA-PDT, because the ALA
agents are difficult to diffuse into OL lesional epithelial
cells through the thick keratin layer. Therefore, if one or
two treatments of cryogun cryotherapy alone are per-
formed to remove the thick keratin layer on the surface of
OL lesions, then the cryotherapy-treated residual OL le-
sions can have a very good response to subsequent topical
ALA-PDT. Therefore, cryogun cryotherapy can be used prior
to or after topical ALA-PDT at the same visit or used alone
prior to topical ALA-PDT to obtain successful treatment
outcomes for oral precancers and cancers treated with
combination therapy.38
Cryotherapy for other potential oral lesions
In addition to oral precancers and cancers, cryotherapy has
also been used for the treatment of mucocele,15,20 oral
hemangioma,13,15,17,20 oral lymphangioma,17 gingival
melanin pigmentation,39e41 oral melanotic macule,42 and
oral lichen planus.17,20 Better clinical outcomes may be
achieved, when oral lichen planus is treated by cryotherapy
combined with systemic administration and local applica-
tion or injection of steroid.43e45 Small oral soft-tissue tu-
mors such as fibroma,20 pyogenic granuloma, and
peripheral odontogenic fibroma46,47 may also be treated by
276 C.-H. Yu et al.cryotherapy. Moreover, because the incidence of OSCC is
high and the prognosis of OSCC is relatively poor in
Taiwan,48,49 cryotherapy may also be used as a palliative
remedy for OSCCs that fail to respond to radical surgical
excision, chemotherapy, and radiotherapy, separately or in
combination.
Conclusion
This article reviewed the studies that used cryotherapy for
the treatment of oral precancers and cancers. Cryotherapy
seems suitable for treating thin or relatively thick plaque-
typed precancerous lesions such as OL. For OVH or OVC
lesions, because these two types of verrucous lesions are
usually fungating and bulky, a combination therapy of shave
excision and subsequent cryotherapy is needed to achieve a
CR of the lesion. OSCCs have also been treated by cryo-
therapy predominantly between 1960 and 1980 with com-
parable treatment outcomes to those treated by surgical
excision. However, it is not the main-stream treatment
modality for OSCCs after 1980s. Using the cryotherapy as
the initial treatment for OSCCs is not recommended. By
careful selection of patients, cryotherapy is a simple, safe,
easy, conservative, and acceptable treatment modality for
certain types of benign oral lesions and oral precancers.
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